Richard M. Johnson has been the President and Chief Executive Officer of the Parenteral Drug Association since September 2009. In this position he has grown PDA globally and focused the organization on Science & Regulatory contributions. Richard has been an active member of PDA for more than 25 years, serving on the Scientific Advisory Board (co-chair); Regulatory Affairs & Quality Control committee; Sterile/Aseptic Processing Interest Group (chair); Aseptic Processing committee (co-chair); GMP and Glass Defects (Chair) Task Forces.
In his 40-year career in the pharmaceutical and medical devices industry, with responsible for facilities throughout US, Europe, Asia and South America, Richard has been a recognized leader with excellent knowledge of US and international regulatory requirements, quality practices, and technical operations, especially in validation, sterilization, aseptic and sterile processing.
Prior positions include Vice President of Global Quality Assurance for Fort Dodge Animal Health (a division of Wyeth), Director of the Corporate Quality Center of Excellence for Abbott Laboratories, and both US and International assignments with Alcon Laboratories and Bausch & Lomb. Richard has M.Sc. and B.Sc. degrees in Biological Sciences from Marshall University. He was also the co- chair of the US Sub-TAG to ISO/TC 198 (Aseptic Processing), and has been active in the PhRMA Bar Code Committee, PQRI Aseptic Processing Working Group, ISPE and the Midwest Quality Discussion Groups since the early 1990’s.